Your browser doesn't support javascript.
loading
First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.
Nishimura, Nobutaka; Miyake, Makito; Shimizu, Takuto; Matsubara, Toshihiko; Miyamoto, Tatsuki; Sakamoto, Keichi; Yamada, Atsushi; Matsumoto, Yoshihiro; Yoshikawa, Motokiyo; Ichikawa, Kazuki; Omori, Chihiro; Maesaka, Fumisato; Oda, Yuki; Kiba, Keisuke; Tomioka, Atsushi; Hosokawa, Yukinari; Tanaka, Masahiro; Otani, Takeshi; Fujimoto, Kiyohide.
Afiliação
  • Nishimura N; Department of Urology, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan.
  • Miyake M; Department of Urology, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan. makitomiyake@yahoo.co.jp.
  • Shimizu T; Department of Urology, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan.
  • Matsubara T; Department of Urology, Gyoumeikan Hospital, Osaka, Japan.
  • Miyamoto T; Department of Urology, Hoshigaoka Medical Center, Hirakata, Osaka, Japan.
  • Sakamoto K; Department of Urology, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan.
  • Yamada A; Department of Urology, Hoshigaoka Medical Center, Hirakata, Osaka, Japan.
  • Matsumoto Y; Department of Urology, Hoshigaoka Medical Center, Hirakata, Osaka, Japan.
  • Yoshikawa M; Department of Urology, Yamato Takada Municipal Hospital, Yamatotakada, Nara, Japan.
  • Ichikawa K; Department of Urology, Kouseikai Takai Hospital, Tenri, Nara, Japan.
  • Omori C; Department of Urology, Nara Prefecture General Medical Center, Nara, Japan.
  • Maesaka F; Department of Urology, Nara City Hospital, Nara, Japan.
  • Oda Y; Department of Urology, Nara Prefecture Seiwa Medical Center, Ikoma, Nara, Japan.
  • Kiba K; Department of Urology, Kindai University Nara Hospital, Ikoma, Nara, Japan.
  • Tomioka A; Department of Urology, Saiseikai Chuwa Hospital, Sakurai, Nara, Japan.
  • Hosokawa Y; Department of Urology, Tane General Hospital, Osaka, Japan.
  • Tanaka M; Department of Urology, Gokeikai Osaka Kaisei Hospital, Osaka, Japan.
  • Otani T; Department of Urology, Matsusaka Chuo General Hospital, Matsusaka, Mie, Japan.
  • Fujimoto K; Department of Urology, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan.
Int J Clin Oncol ; 27(11): 1733-1741, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36029377

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Urológicas Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Urológicas Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article